Unilever (LON:ULVR) Stock Rating Reaffirmed by Berenberg Bank

Unilever (LON:ULVRGet Free Report)‘s stock had its “buy” rating restated by research analysts at Berenberg Bank in a note issued to investors on Thursday, Marketbeat.com reports. They presently have a GBX 4,960 ($61.26) target price on the stock. Berenberg Bank’s price target points to a potential upside of 20.01% from the company’s current price.

Other equities research analysts have also recently issued research reports about the stock. Barclays reiterated an “overweight” rating and set a GBX 4,600 ($56.82) target price on shares of Unilever in a research report on Monday, April 8th. Jefferies Financial Group restated an “underperform” rating and issued a GBX 3,400 ($42.00) price objective on shares of Unilever in a research report on Wednesday, March 20th.

View Our Latest Research Report on Unilever

Unilever Trading Up 1.2 %

Shares of Unilever stock opened at GBX 4,133 ($51.05) on Thursday. The stock has a market capitalization of £103.74 billion, a P/E ratio of 1,878.64, a price-to-earnings-growth ratio of 14.44 and a beta of 0.17. The company has a quick ratio of 0.49, a current ratio of 0.76 and a debt-to-equity ratio of 142.66. The company has a 50-day simple moving average of GBX 3,897.46 and a 200 day simple moving average of GBX 3,868.62. Unilever has a 12-month low of GBX 3,680.50 ($45.46) and a 12-month high of GBX 4,483.25 ($55.38).

About Unilever

(Get Free Report)

Unilever PLC operates as a fast-moving consumer goods company in the Asia Pacific, Africa, the Americas, and Europe. It operates through five segments: Beauty & Wellbeing, Personal Care, Home Care, Nutrition, and Ice Cream. The Beauty & Wellbeing segment engages in the sale of hair care products, such as shampoo, conditioner, and styling; skin care products including face, hand, and body moisturizer; and prestige beauty and health & wellbeing products consist of the vitamins, minerals, and supplements.

Featured Stories

Receive News & Ratings for Unilever Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Unilever and related companies with MarketBeat.com's FREE daily email newsletter.